FDA
-
-
-
-
-
-
-
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model
-
-
-
-
-
-
-
Lunai Bioworks develops AI platform for neurotoxic compound detection
-
330,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

